August 2022 Issue of The Ophthalmologist

In this month’s editorial, Geoffrey Potjewyd discusses the recent allegations of image manipulation in a major Alzheimer’s disease paper and the importance of research integrity.
Our Upfront section covers features the latest industry and research news – the pandemic’s effect on AMD progression, a single injection that could treat inherited blindness, a pathway that lets people see shadows in the dark, and ethnic disparities in vision loss risk in primary open angle glaucoma patients.
This issue’s cover feature is a double bill! In the first part, some of the biggest names in the field – John Hovanesian, Oliver Findl, David Chang, and Dan Morris – highlight the issue of sustainability and discuss the initiatives being undertaken to reduce ophthalmology’s environmental impact. Following this is the annual Art of Eyes gallery feature, showcasing the best ophthalmic images created by photographers, cartoonists, painters, and even those using artificial intelligence to assist with their artistic endeavors.
In our Cornea and OSD section, Richard L. Lindstrom assesses the cost-effectiveness of corneal collagen cross-linking for keratoconus, and in Glaucoma, Robert A. Van der Vaart talks about the benefit of incorporating MIGS into comprehensive practice and shares his favorite device. In the Retina section, Thomas Aaberg, Jr. discusses how encapsulated cell therapy could offer a continuous and targeted treatment for under- and untreated eye diseases.
Finally, we sit down with Marc Safran, Former Medical Director, Syracuse Specialty Surgery Center, and an award-winning photographer, based in Syracuse, New York, USA.